Oculotronics
Latest round
- Series A
Last raised
- Jun 2026
Total raised
- $15M
Investors
- 2
About Oculotronics
, dba Oculotronics, is a medical device company specializing in the development of ophthalmic surgical robots. The core team is from the Technical University of Munich (Germany), Zurich University of Technology (Switzerland), Sun Yat-sen University and Sun Yat-sen University Zhongshan Ophthalmic Center. In addition, its core team has more than ten years of experience in software automation, engineering, AI, medicine and other fields. The company successfully conducted the world's first 5G remote micron-sized eye surgery on June 23, 2023. The company self-develop fundus surgery systems, precision drug delivery systems and ophthalmic training systems. It has also developed a high-precision ophthalmic surgical robot called Clippard that can perform vitreoretinal surgery, intraocular injections, fundus injections, corneal transplants, and cataract surgery. The company generates revenue from the sales of ophthalmic surgical robotics.
Who invested in Oculotronics
2 investors across 1 round
See all investors in Oculotronics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 9, 2026
Amount
$15M
Investors
Questions about Oculotronics
Who invested in Oculotronics?
Oculotronics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Oculotronics raised?
Oculotronics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Oculotronics last raise money?
Oculotronics's most recent round on record is a Series A, in Jun 2026.
What does Oculotronics do?
, dba Oculotronics, is a medical device company specializing in the development of ophthalmic surgical robots.
Where is Oculotronics headquartered?
Oculotronics is headquartered in Guangzhou, China.
Which VCs invest in companies like Oculotronics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Oculotronics's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Oculotronics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.